However, growing evidence suggests that GM-CSF is produced in disease and locally active at sites of tissue inflammation, for example, in late-phase cutaneous reactions, rheumatoid arthritis, inflammatory pain, and multiple sclerosis [58–63]. The gene discussed is CSF2; the disease is multiple sclerosis.